Total Payments
$310,565
2024 Payments
$66,219
Companies
55
Transactions
952
Medicare Patients
15,734
Medicare Billing
$749,454
Payment Breakdown by Category
Other$267,023 (86.0%)
Food & Beverage$18,471 (5.9%)
Travel$17,939 (5.8%)
Consulting$6,988 (2.2%)
Education$144.20 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $267,023 | 78 | 86.0% |
| Food and Beverage | $18,471 | 777 | 5.9% |
| Travel and Lodging | $17,939 | 81 | 5.8% |
| Consulting Fee | $6,988 | 9 | 2.2% |
| Education | $144.20 | 7 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $198,513 | 164 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $45,390 | 73 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $28,434 | 264 | $0 (2023) |
| Lilly USA, LLC | $14,766 | 26 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $7,467 | 44 | $0 (2024) |
| Abbott Laboratories | $2,368 | 49 | $0 (2024) |
| Penumbra, Inc. | $2,298 | 6 | $0 (2024) |
| ABIOMED | $1,605 | 25 | $0 (2024) |
| Terumo Medical Corporation | $1,563 | 13 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,257 | 63 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $66,219 | 135 | Novo Nordisk Inc ($54,166) |
| 2023 | $55,660 | 120 | Novo Nordisk Inc ($49,811) |
| 2022 | $78,402 | 134 | Novo Nordisk Inc ($47,405) |
| 2021 | $56,916 | 123 | Novo Nordisk Inc ($46,858) |
| 2020 | $5,731 | 84 | Boehringer Ingelheim Pharmaceuticals, Inc. ($3,800) |
| 2019 | $31,065 | 148 | Boehringer Ingelheim Pharmaceuticals, Inc. ($19,715) |
| 2018 | $14,707 | 113 | Boehringer Ingelheim Pharmaceuticals, Inc. ($9,081) |
| 2017 | $1,864 | 95 | Terumo Medical Corporation ($642.72) |
All Payment Transactions
952 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $42.11 | General |
| 12/13/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $16.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $17.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,943.75 | General |
| 11/05/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Stents | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $21.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $4.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Cardio-renal | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $8,331.25 | General |
| 10/16/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $575.83 | General |
| 10/16/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $574.33 | General |
| 10/16/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $403.90 | General |
| 10/16/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $136.44 | General |
| 10/16/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $15.00 | General |
| 10/15/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.48 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 3,589 | 4,891 | $470,683 | $171,253 |
| 2022 | 39 | 3,709 | 5,436 | $483,563 | $170,135 |
| 2021 | 38 | 3,949 | 5,870 | $532,280 | $189,593 |
| 2020 | 40 | 4,487 | 6,545 | $597,865 | $218,473 |
Total Patients
15,734
Total Services
22,742
Medicare Billing
$749,454
Procedure Codes
161
All Medicare Procedures & Services
161 procedure records from CMS Medicare Utilization — Page 7 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93971 | Ultrasound scan of veins of one arm or leg or limited including assessment of compression and functional maneuvers | Facility | 2020 | 22 | 33 | $1,452 | $584.58 | 40.3% |
| 93280 | Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report | Office | 2020 | 18 | 23 | $1,748 | $556.94 | 31.9% |
| 93978 | Ultrasound scan of vena cava or groin graft or vessel blood flow | Facility | 2020 | 16 | 17 | $1,309 | $534.46 | 40.8% |
| 93308 | Follow-up or limited ultrasound examination of heart | Facility | 2020 | 23 | 24 | $1,224 | $492.32 | 40.2% |
| 93922 | Ultrasound study of arteries of both arms and legs | Facility | 2020 | 51 | 53 | $1,325 | $483.89 | 36.5% |
| 93320 | Doppler ultrasound study of heart blood flow, valves, and chambers | Facility | 2020 | 30 | 30 | $1,080 | $438.71 | 40.6% |
| 0298T | Review and interpretation of external ekg recording for more than 48 hours up to 21 days | Office | 2020 | 22 | 23 | $1,242 | $435.91 | 35.1% |
| 93293 | Telephonic evaluation of single, dual, or multiple lead pacemaker heart rhythm strips up to 90 days | Office | 2020 | 13 | 17 | $1,615 | $419.54 | 26.0% |
| 99152 | Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes | Facility | 2020 | 21 | 24 | $783.00 | $236.48 | 30.2% |
| 0296T | External ekg recording for more than 48 hours up to 21 days | Office | 2020 | 11 | 11 | $539.00 | $183.22 | 34.0% |
| 93325 | Doppler ultrasound study of color-directed heart blood flow, rate, and valve function | Facility | 2020 | 30 | 30 | $210.00 | $76.55 | 36.5% |
About Dr. Steve Lin, MD
Dr. Steve Lin, MD is a Cardiovascular Disease healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518979111.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steve Lin, MD has received a total of $310,565 in payments from pharmaceutical and medical device companies, with $66,219 received in 2024. These payments were reported across 952 transactions from 55 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($267,023).
As a Medicare-enrolled provider, Lin has provided services to 15,734 Medicare beneficiaries, totaling 22,742 services with total Medicare billing of $749,454. Data is available for 4 years (2020–2023), covering 161 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology, Nuclear Cardiology
- Location Lexington, KY
- Active Since 08/12/2006
- Last Updated 04/08/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1518979111
Products in Payments
- JARDIANCE (Drug) $60,085
- Ozempic (Drug) $52,437
- XARELTO (Drug) $28,563
- Rybelsus (Drug) $21,657
- Wegovy (Drug) $17,334
- RYBELSUS (Drug) $6,445
- FARXIGA (Drug) $4,150
- LOKELMA (Drug) $2,494
- Indigo System (Device) $2,141
- CardioMEMS HF System (Device) $1,678
- Impella (Device) $1,605
- ONYX FRONTIER (Device) $1,244
- ENTRESTO (Drug) $961.06
- NAVICROSS (Device) $843.16
- BRILINTA (Drug) $801.77
- COOK MEDICAL FILTERS (Device) $525.83
- CARDIOMEMS (Device) $433.23
- Repatha (Biological) $413.52
- LEQVIO (Drug) $295.58
- MULTAQ (Drug) $291.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Lexington
Dr. William Skinner, Md, MD
Cardiovascular Disease — Payments: $463,034
Cardiovascular Disease $463,034
Dr. Joseph Souza, M.d, M.D
Cardiovascular Disease — Payments: $238,102
Cardiovascular Disease $238,102
Gery Tomassoni, M.d, M.D
Cardiovascular Disease — Payments: $215,300
Cardiovascular Disease $215,300
Armaghan Soomro, Md, MD
Cardiovascular Disease — Payments: $114,497
Cardiovascular Disease $114,497
Dr. Adrian Messerli, Md, MD
Cardiovascular Disease — Payments: $67,777
Cardiovascular Disease $67,777
Himadri Dasgupta, Md, MD
Cardiovascular Disease — Payments: $42,982
Cardiovascular Disease $42,982